Literature DB >> 3135350

Radiotherapy in the treatment of ameloblastoma.

D G Gardner1.   

Abstract

There is a lack of well-documented evidence in the literature concerning the relative radioresponsiveness or radioresistance of ameloblastomas, although they are generally considered radioresistant. Most of the previous papers referring to this subject lack acceptable histopathologic proof of the diagnosis, adequate radiotherapeutic data, and/or follow-up information; many predate the use of megavoltage irradiation. The present article reports 5 cases of ameloblastoma that were treated by radiotherapy, 3 by megavoltage irradiation. All have been confirmed histologically by an oral pathologist, all have adequate radiotherapeutic data and, with one exception, adequate follow-up information. In addition, the reasons for our present lack of knowledge of this subject are discussed; objective criteria are presented for evaluating the results of radiotherapy on ameloblastomas; the only other series of ameloblastomas treated by megavoltage irradiation is analyzed. Although radiotherapy can reduce the size of an ameloblastoma, primarily that part of the tumor which has expanded the jaw or broken into the soft tissues, it does not appear to be an appropriate treatment for an operable ameloblastoma. Its main use is in inoperable cases, primarily in the posterior maxilla.

Entities:  

Mesh:

Year:  1988        PMID: 3135350     DOI: 10.1016/s0901-5027(88)80033-x

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  8 in total

1.  Ameloblastic carcinoma of the maxilla with extension into the ethmoidal air cells and close proximity to the anterior skull base: a rare case presentation.

Authors:  Colin J Perumal
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2012-09

Review 2.  Ameloblastoma: a clinical review and trends in management.

Authors:  Andrew C McClary; Robert B West; Ashley C McClary; Jonathan R Pollack; Nancy J Fischbein; Christopher F Holsinger; John Sunwoo; A Dimitrios Colevas; Davud Sirjani
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-30       Impact factor: 2.503

3.  Ameloblastic carcinoma.

Authors:  Hari Ram; Shadab Mohammad; Nuzhat Husain; Prem Narayan Gupta
Journal:  J Maxillofac Oral Surg       Date:  2011-03-17

Review 4.  Ameloblastoma, a rare benign odontogenic tumour: an interesting tumour review targeting the role of radiation therapy.

Authors:  G V Koukourakis; A Miliadou; A Sotiropoulou-Lontou
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

Review 5.  Pattern of care and impact of prognostic factors in the outcome of ameloblastic carcinoma: a systematic review and individual patient data analysis of 199 cases.

Authors:  Prashanth Giridhar; Supriya Mallick; Ashish Datt Upadhyay; Goura K Rath
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-09       Impact factor: 2.503

6.  Recurrent ameloblastoma in temporal fossa: A diagnostic dilemma.

Authors:  Sagar S Vaishampayan; Deepa Nair; Asawari Patil; Pankaj Chaturvedi
Journal:  Contemp Clin Dent       Date:  2013-04

7.  Ameloblastic carcinoma: A clinicopathologic dilemma - Report of two cases with total review of literature from 1984 to 2012.

Authors:  Indu Bhusan Kar; R V Subramanyam; Niranjan Mishra; Akhilesh Kumar Singh
Journal:  Ann Maxillofac Surg       Date:  2014-01

8.  Incidence and overall survival of malignant ameloblastoma.

Authors:  Alexandra Rizzitelli; Nicolas R Smoll; Michael P Chae; Warren M Rozen; David J Hunter-Smith
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.